{"id":"W2237180614","doi":"10.1016/s0140-6736(16)00048-9","title":"Ixekizumab for psoriasis – Authors' reply","year":2016,"lang":"en","type":"letter","venue":"The Lancet","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Psoriasis; Scopus; Ixekizumab; Medicine; Psychosocial; Depression (economics); Etanercept; Disease; Psychiatry; Immunology; MEDLINE; Internal medicine; Tumor necrosis factor alpha; Psoriatic arthritis; Secukinumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003828586,0.0008637679,0.001864354,0.0008605649,0.002751511,0.004946169,0.001791675,0.05769301,0.005514015],"category_scores_gemma":[0.02332176,0.000929721,0.001361482,0.0006084345,0.003381551,0.003733935,0.002441596,0.04732111,0.005095518],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002872825,"about_ca_system_score_gemma":0.003131863,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002505954,"about_ca_topic_score_gemma":0.003402557,"domain_scores_codex":[0.9957586,0.001328488,0.0004963098,0.0005594813,0.001273013,0.0005841139],"domain_scores_gemma":[0.9919448,0.00443707,0.0008180618,0.0002784706,0.001237895,0.001283599],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006635929,0.0000206132,0.0003264332,0.00005827322,0.00002593144,0.0008727515,0.00009896259,0.00004118255,0.0001180579,0.001333139,0.9926338,0.004404537],"study_design_scores_gemma":[0.000236698,0.00008407498,0.0008258362,0.0003353836,0.00005805925,0.001378947,0.0004234734,0.0002276936,0.0002694723,0.007456096,0.988622,0.00008228543],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.0001750992,0.002797868,0.00004799393,0.9539174,0.04197126,0.000007084237,0.00004002402,0.00001693518,0.001026307],"genre_scores_gemma":[0.002537381,0.001123608,0.00007944928,0.9380147,0.05446055,0.0000213092,0.00001939143,0.0000164135,0.003727236],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.05769301,"threshold_uncertainty_score":0.02084392,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03980343883148937,"score_gpt":0.269108292380619,"score_spread":0.2293048535491296,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}